Furthermore, we have found that the TME of GBM patients has significantly higher levels of CD4, CD39, CD73, TIM3, IL-10 and TGFB1 transcripts, pointing toward high levels of Treg cells (Fig. 5C–H). This evidence concerns the gene TGFB1 and glioblastoma.